Skip to main content

Stryker Corporation Spinal Implants revenue

  • SYK · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$309.64−0.88%Close 13 Nov 2026

Spinal Implants revenue at Stryker Corporation came to $4.0M for the quarter to 30 Sep 2026, down 33.3% from a year earlier.

As Stryker Corporation reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$171.0MMar 2024$178.0MJun 2024$172.0MSep 2024$186.0MDec 2024$166.0MMar 2025$5.0MJun 2025$6.0MSep 2025$2.0MMar 2026$3.0MJun 2026$4.0MSep 2026
Stryker Corporation Spinal Implants revenue, every reported period
Period endingSpinal Implants revenueChange on a yearFiled
30 Sep 2026$4.0Mdown 33.3%30 Oct 2026
30 Jun 2026$3.0Mdown 40.0%26 Jun 2026
31 Mar 2026$2.0Mdown 98.8%11 May 2026
30 Sep 2025$6.0Mdown 96.5%31 Oct 2025
30 Jun 2025$5.0Mdown 97.2%1 Aug 2025
31 Mar 2025$166.0Mdown 2.9%2 May 2025
31 Dec 2024$186.0M—12 Feb 2025
30 Sep 2024$172.0M—30 Oct 2024
30 Jun 2024$178.0M—31 Jul 2024
31 Mar 2024$171.0M—1 May 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Stryker Corporation: Organic net sales (change on a year) · Neuro Cranial Instruments revenue · Orthopaedic Instruments revenue · Neuro Cranial - Interventional Spine revenue · Enabling Technologies revenue · Medical revenue · Endoscopy revenue · Trauma and Extremities revenue · Instruments revenue · Instruments (earlier basis) revenue · Ortho Tech revenue · Neuro Cranial revenue · Knees revenue · Vascular revenue · Hips revenue · MedSurg and Neurotechnology (revenue) · Orthopaedics (revenue) · United States revenue · Europe, Middle East, Africa revenue · Asia Pacific revenue · International revenue · financial statements

Every KPI and segment of SYK, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.